{"disease":{"id":"eosinophilic-gastritis","name":"eosinophilic gastritis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02523118","title":"OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages","phase":"","overall_status":"RECRUITING","enrollment_count":1350,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05219903","title":"National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT04322604","title":"A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT04620811","title":"An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT03496571","title":"A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT03664960","title":"An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT03678545","title":"Dupilumab in Eosinophilic Gastritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":true},{"nct_id":"NCT05229432","title":"Study of Gastric Motility in Eosinophilic Gastritis","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03473977","title":"Benralizumab for Eosinophilic Gastritis (BEGS)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":true},{"nct_id":"NCT05831176","title":"A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05579444","title":"Systems Biology of Gastrointestinal and Related Diseases","phase":"","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Viome","has_results":false},{"nct_id":"NCT05251909","title":"Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"AstraZeneca","has_results":true}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}